Dabigatran is one of the new generation oral anticoagulants. To use Dabigatran drug safely and effectively, patients need to understand clearly about its uses, usage, adherence to treatment as well as monitor side effects under the guidance of doctors and pharmacists.

Apixaban is indicated for the prevention of stroke and embolism in patients with non-valvular atrial fibrillation, the treatment of deep vein thrombosis and pulmonary embolism, and the prevention of venous thrombosis in patients undergoing knee replacement or replacement. hip joint. To use the drug effectively and safely, the patient needs to follow the instructions of the doctor, the pharmacist who prescribes it.

Currently, the prevalence of atrial fibrillation in the population is about 0.4%, this rate increases with age. Atrial fibrillation causes many cardiovascular events, causing death or lifelong disability, above all, treatment methods are still limited and difficult. Therefore, the issue of stroke prevention in patients with atrial fibrillation is also of great concern.